[This unedited press release is made available courtesy of Gamasutra and its partnership with notable game PR-related resource GamesPress.]

London, UK – April 19, 2012 –Today, Ubisoft announced House, M.D.™: Critical Cases is now available onFacebook. Based upon the hit television show, HOUSE, the gameallows fans to join House and his team at Princeton-PlainsboroTeaching Hospital to investigate and uncover medical mysteries.Working alongside their favourite characters from the show andtheir Facebook friends, players race against the clock to diagnoseand cure the most critical cases.  House, M.D.: Critical Cases is licensed through UniversalPartnerships & Licensing on behalf of NBCUniversal TelevisionConsumer Products Group.

Interact with Characters from the Show

Consult with House and his team on the most mysterious cases byrunning lab tests, investigating symptoms and examiningenvironmental causes to diagnose patients. 

Manage your Own Hospital

Run your own Princeton-Plainsboro Teaching Hospital by screeningclinic patients, managing lab resources and overseeing pharmacysupplies.

Work alongside your Facebook Friends

Hire friends to help out and perform diagnostic tests, treatreferrals and revive crashed patients to save as many lives aspossible. 

Exclusive to Facebook

House, M.D.: Critical Cases is specifically designed for socialgamers. It’s easy to pick up and play, plus it’sabsolutely free.

House, M.D.: Critical Cases can be found on Facebookhere: https://apps.facebook.com/housemd-game

Ubisoft is a leading producer, publisher and distributor ofinteractive entertainment products worldwide and has grownconsiderably through a strong and diversified line-up of productsand partnerships. Ubisoft has offices in 26 countries and has salesin more than 55 countries around the globe. it is committed todelivering high-quality, cutting-edge video game titles toconsumers. for the 2010-11 fiscal year Ubisoft generated sales of€1,039 million. To learn more, please visit: ubisoftgroup.com.

© 2011 Universal Network Television LLC. House M.D. is atrademark and copyright of Universal Network Television LLC.Licensed by Universal Studios Licensing LLC.  all RightsReserved. Software © 2011 Ubisoft Entertainment. all RightsReserved. Ubisoft and the Ubisoft logo are trademarks of UbisoftEntertainment in the US and/or other countries.

Ubisoft Limited. Registered number: 2409000 England & Wales.Registered office: First Floor, Chertsey Gate East, London Street,Chertsey, Surrey, KT16 8AP

Information contained in this e-mail is intended for the use ofthe addressee only, and is confidential and may also be privileged.If you receive this message in error, please advise us immediately.If you are not the intended recipient(s), please note that any formof distribution, copying or use of this communication or theinformation in it is strictly prohibited and may be unlawful.Opinions, conclusions and other information in this message that donot relate to the official business of Ubisoft Limited shall beunderstood as neither given nor endorsed by it. Attachments to thise-mail may contain software viruses which may damage your systems. 

Market adoption of Meridian Bioscience’s (NASDAQ:VIVO) new molecular diagnostic testing platform illumigene will go a long way toward determining the company’s future.

Cincinnati-area Meridian is betting big on the technology, hoping it’ll help rescue the diagnostic testing company from its recent struggles. the company has reported declining year-over-year earnings in several recent quarters and twice in the last few months downwardly revised its full-year earnings outlook for 2011.

Meridian’s illumigene platform provides its hospital and laboratory customers with a simpler, cheaper option to test samples for certain types of bacteria without the use of expensive instrumentation. It represents Meridian’s first foray into molecular diagnostics, a means of analyzing the makeup of an organism at the genetic level.

AdvertisementMolecular diagnostic tests tend to offer better sensitivity and specificity than their antibody-based counterparts, said Zarak Khurshid, a senior research analyst with Wedbush Securities. “the world appears to be moving in the direction of molecular tests,” he said.

So for Meridian to stay at the cutting edge of its industry and build the best products it can, the company’s push into molecular diagnostics must succeed.

“Illumigene is critically important to Meridian’s future — the reason being that the diagnostic space is fiercely competitive,” Khurshid said.

Thus far, Meridian has just one illumigene test on the market, for C. difficile, a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. CEO Jack Kraeutler said in July that Meridian expects to begin selling a second illumigene test, for Group B Streptococcus, to international markets before the end of the year.

Kraeutler said at the time that the company had achieved 500 “placements” of the test, with 90 percent of those in the U.S. Those sales contributed $6 million in revenue in 2011. (Kraeutler didn’t return calls for this article.)

That performance is a little better than Khurshid had expected, though he warned the true test of the illumigene platform will be whether it can help Meridian regain market share it’s lost to competitors like Cepheid, Becton Dickinson and Thermo Fisher Scientific.

Cepheid, in particular, has bruised Meridian with a molecular C. difficile test that came on the market in 2009. Khurshid estimates that the Cepheid test has taken a 10 percent bite out of Meridian’s market share in each of the last two years.

If Meridian is going to succeed, it needs to turn that around quickly — and that’s among the company’s biggest looming challenges.

“the jury is still out as to whether illumigene will allow Meridian to take back some of its lost market share and whether they can develop additional tests on that platform to build a meaningful, high-growth franchise in molecular diagnostics,” Khurshid said.

Cervical Cancer Symptoms after Hysterectomy

Cervical Cancer Symptoms after Hysterectomy

Every year over 11,000 women in the U.S. are diagnosed with this cancer.  Cervical Cancer Symptoms after Hysterectomy If it is diagnosed early, treatment can be successful.  On the other hand, a misdiagnosis can result in delayed treatment.  without the proper treatment, the survival rate decreases considerably and it may lead to death.

There are medical attorneys that will represent victims who had a misdiagnosis of with cancer.  Speak with an attorney regarding the claim; they will evaluate your case free of charge.

How Cervical Cancer Is Diagnosed

Sexually active women should go have regular Pap smears.  While Pap smears are not a diagnostic test, they are used to spot abnormal cells.  If abnormal cells are present, further tests should be ordered to make a positive diagnosis.  Some diagnostic tests include:

Colposcopy – an instrument called a colposcope is used to look at the cervix and see more clearly areas of abnormal cell growth Biopsy – a sample of abnormal tissue is taken from the cervix for testing Endocervical scraping – a specialized instrument is used to scrape tissue lining the endocervical canal, an area the doctor cannot reach with the colposcope Cone biopsy – a cone-shaped piece of tissue is removed from the cervix

Not overseeing diagnostic tests or misinterpreting the results can put off successful treatment options and the consequences can be fatal.

How Misdiagnosis Occurs

Lung Cancer Secrets Revealed Click here

A missed or wrong diagnosis of cervical cancer may occur for the following reasons:

the doctor fails to recognize symptoms of cervical cancer, thereby failing to perform the tests necessary for diagnosis the doctor fails to obtain a full patient history, which is important for identifying risk factors such as Human Papilloma Virus (HPV) Lab results are misinterpreted A laboratory error causes the patient’s results to be confused with another patient’s

There are many types of misdiagnosis.  Delayed diagnosis, missed diagnosis and wrong diagnosis can each have their own consequence.  for instance, a wrong diagnosis of cancer when a patient does not have it can mean a person undergoing treatments that are not needed.  In addition, if cancer was missed, a patient will not receive treatment they actually need to live.

Have you been Misdiagnosed?

If you were misdiagnosed with cervical cancer, there is legal action you can take and with the help of a medical attorney, it can happen.  the negligent party can be held liable and a victim can recover some compensation for damages lost.  This can include lost wages, treatment costs, pain, and suffering.

Contact an attorney to learn more about your legal rights if you have received a misdiagnosis of cervical cancer.  They will evaluate your case at no cost and advise you of your rights.

lung cancer treatment breakthroughs Click here

Incoming search terms for the article:

1. Cervical Cancer Symptoms Mayo
2. Cervical Cancer Symptoms | Cervical Cancer Symptoms as well as a one Minute Treatment
3. Cervical Cancer ? Symptoms as well as Causes of Cervical Cancer
4. Cervical Cancer Symptoms And Signs, Lessons to Be Learnt From Jade Goody
5. Cervical Cancer Symptoms Bleeding

Diabetes appears to be associated with the risk of depression and vice versa, suggesting the relationship between the two works in both directions, according to a report in the November 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

An estimated 23.5 million U.S. adults?more than 10 percent?have diabetes, including 23 percent of those ages 60 and older, according to background information in the article. Major depressive disorder affects about 14.8 million U.S. adults each year. “Although it has been hypothesized that the diabetes-depression relation is bidirectional, few studies have addressed this hypothesis in a prospective setting,” the authors write.

An Pan, Ph.D., of the Harvard School of Public Health, Boston, and colleagues assessed the relationship between the two diseases among 65,381 women who were age 50 to 75 in 1996. Participants completed an initial questionnaire about their medical history and health practices, and then follow-up questionnaires every two years through 2006. they were classified as having depression if they reported symptoms of depression, using antidepressant medication or being given a diagnosis of depression by a physician. Women who reported a new diagnosis of diabetes completed a supplementary questionnaire about symptoms, diagnostic tests and treatments.

During the 10-year follow-up, 2,844 women were diagnosed with type 2 diabetes and 7,415 developed depression. Women with depression were about 17 percent more likely to develop diabetes after controlling for other risk factors, such as physical activity and body mass index (BMI). those who were taking antidepressants had a 25 percent higher risk of developing diabetes than those who did not have depression.

After controlling for other risk factors for mood disorders, women with diabetes were 29 percent more likely to develop depression. Women who took insulin for diabetes had a further increased risk?53 percent higher than women without diabetes.

“The findings from this well-characterized cohort of more than 55,000 U.S. women with 10 years’ follow-up add to the growing evidence that depression and diabetes are closely related to each other, and this reciprocal association also depends on the severity or treatment of each condition,” the authors write. “All the associations were independent of sociodemographic, diet and lifestyle factors.”

The results indicate that lifestyle factors such as physical activity and BMI may partially mediate the association between depression and new cases of diabetes, but since the association remained significant after adjusting for these factors, depression may have an effect on risk for diabetes beyond weight and inactivity. In addition, the findings reinforce the idea that diabetes is related to stress, the authors note. “A diagnosis of diabetes may lead to the symptoms of depression for the following reasons: depression may result from the biochemical changes directly caused by diabetes or its treatment, or from the stresses and strains associated with living with diabetes and its often debilitating consequences,” they write.

“Future studies are needed to confirm our findings in different populations and to investigate the potential mechanisms underlying this association,” the authors conclude. “Furthermore, depression and diabetes are highly prevalent in the middle-aged and elderly population, particularly in women. thus, proper lifestyle interventions including adequate weight management and regular physical activity are recommended to lower the risk of both conditions.”

(Arch Intern Med. 2010;170[21]:1884-1891. Available pre-embargo to the media at jamamedia.org.)

Editor’s Note: This study was supported by a National Institutes of Health grant. Co-author Dr. Ascherio received a grant from the National Alliance for Research on Schizophrenia & Depression. Co-author Dr. Lucas received a postdoctoral fellowship from the Fonds de recherché en santé du Quebéc. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact corresponding author Frank B. Hu, M.D., Ph.D., call Todd Datz at 617-998-8819 or e-mail .

For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail .